Opportunities

ITI will work with off-patent drugs, in-licensed drugs or new compounds and apply our nasal drug delivery expertise and technology. We intend to sell directly, co-promote or out-license newly developed pharmaceutical products. This approach provides potential partners with a variety of opportunities, including:

• Developing new delivery methods for existing drugs with known safety and performance characteristics, thus reducing the time and resources required to develop a new product and bring it to market.
• Enhancing product life cycle management and extending the patent life of prescription pharmaceuticals.
• Generating new intellectual property by applying novel drug delivery methods.
• Developing new therapies, such as for pain and central nervous system disorders, and setting up a small specialized sales and marketing organization.
• Improving the safety, efficacy and ease of administration of peptide/protein drugs, vaccines and small molecule drugs. With vaccines, nasal delivery stimulates mucous membranes’ immune response, thus improving the vaccine’s efficacy.